These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35174448)

  • 1. Stem cell therapy for COVID-19 pneumonia.
    Kebria MM; Milan PB; Peyravian N; Kiani J; Khatibi S; Mozafari M
    Mol Biomed; 2022 Feb; 3(1):6. PubMed ID: 35174448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
    Akbari A; Rezaie J
    Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.
    Ahmed SH; AlMoslemany MA; Witwer KW; Tehamy AG; El-Badri N
    Stem Cell Rev Rep; 2024 May; 20(4):900-930. PubMed ID: 38393666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
    Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
    CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
    Ringdén O; Moll G; Gustafsson B; Sadeghi B
    Front Immunol; 2022; 13():839844. PubMed ID: 35371003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical progress: Stem cells as a new therapeutic strategy for COVID-19.
    Musial C; Gorska-Ponikowska M
    Stem Cell Res; 2021 Apr; 52():102239. PubMed ID: 33601098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives.
    Mattoli S; Schmidt M
    Adv Ther; 2023 Jun; 40(6):2626-2692. PubMed ID: 37069355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives.
    Yao W; Shi L; Zhang Y; Dong H; Zhang Y
    Stem Cell Res Ther; 2022 Mar; 13(1):124. PubMed ID: 35321737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.
    Alnefaie A; Albogami S
    Saudi Pharm J; 2020 Nov; 28(11):1333-1352. PubMed ID: 32905015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
    Canham MA; Campbell JDM; Mountford JC
    J Transl Med; 2020 Sep; 18(1):359. PubMed ID: 32958009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells and COVID-19: What they do and what they can do.
    Abu-El-Rub E; Khasawneh RR; Almahasneh F; Altaany Z; Bataineh N; Zegallai H; Sekaran S
    World J Stem Cells; 2021 Sep; 13(9):1318-1337. PubMed ID: 34630865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Therapy: The Hope for Covid-19.
    Nobari S; Rezvan M; Dashtestani F; Gangi M; Keshmiri Neghab H
    Avicenna J Med Biotechnol; 2022; 14(2):104-113. PubMed ID: 35633981
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.